Gene · 623
Papers2,473
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 2,473
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Endothelium Infection and Dysregulation by SARS-CoV-2: Evidence and Caveats in COVID-19. | Viruses | 2020 | 33375371 | PubTator, text mining | PubMed |
| Endothelial activation and dysfunction in COVID-19: from basic mechanisms to potential therapeutic approaches. | Signal Transduct Target Ther | 2020 | 33361764 | PubTator, text mining | PubMed |
Heart failure medication after a first hospital admission and risk of heart failure readmission, focus on beta-blockers and renin-angiotensin-aldosterone system medication: A retrospective cohort study in linked databases. | PLoS One | 2020 | 33351823 | PubTator, text mining | PubMed |
| GPCR Activation States Induced by Nanobodies and Mini-G Proteins Compared by NMR Spectroscopy. | Molecules | 2020 | 33348734 | PubTator, text mining | PubMed |
| Transcutaneous cervical vagal nerve stimulation reduces sympathetic responses to stress in posttraumatic stress disorder: A double-blind, randomized, sham controlled trial. | Neurobiol Stress | 2020 | 33344717 | PubTator, text mining | PubMed |
| Biological and physical approaches on the role of piplartine (piperlongumine) in cancer. | Sci Rep | 2020 | 33335138 | PubTator, text mining | PubMed |
| COVID-19 and haemodynamic failure: a point of view on mechanisms and treatment. | Anaesthesiol Intensive Ther | 2020 | 33327700 | PubTator, text mining | PubMed |
| mTORC1 Transcriptional Regulation of Ribosome Subunits, Protein Synthesis, and Molecular Transport in Primary Human Trophoblast Cells. | Front Cell Dev Biol | 2020 | 33324640 | PubTator, text mining | PubMed |
| Challenges and Opportunities from Targeting Inflammatory Responses to SARS-CoV-2 Infection: A Narrative Review. | J Clin Med | 2020 | 33322733 | PubTator, text mining | PubMed |
| Involvement of Bradykinin Receptor 2 in Nerve Growth Factor Neuroprotective Activity. | Cells | 2020 | 33321704 | PubTator, text mining | PubMed |
Angiotensin-converting enzyme 2, the complement system, the kallikrein-kinin system, type-2 diabetes, interleukin-6, and their interactions regarding the complex COVID-19 pathophysiological crossroads. | J Renin Angiotensin Aldosterone Syst | 2020 | 33283602 | PubTator, text mining | PubMed |
| Optimizing Perioperative Use of Opioids: A Multimodal Approach. | Curr Anesthesiol Rep | 2020 | 33281504 | PubTator, text mining | PubMed |
| Pharmacodynamic and pharmacokinetic behavior of landiolol during dobutamine challenge in healthy adults. | BMC Pharmacol Toxicol | 2020 | 33239108 | PubTator, text mining | PubMed |
| Association of β-blocker use with survival and pulmonary function in patients with chronic obstructive pulmonary and cardiovascular disease: a systematic review and meta-analysis. | Eur Heart J | 2020 | 33211823 | PubTator, text mining | PubMed |
| Altered kinetics of circulating progenitor cells in cardiopulmonary bypass (CPB) associated vasoplegic patients: A pilot study. | PLoS One | 2020 | 33211740 | PubTator, text mining | PubMed |
| ACE2 in the Era of SARS-CoV-2: Controversies and Novel Perspectives. | Front Mol Biosci | 2020 | 33195436 | PubTator, text mining | PubMed |
| SARS-CoV-2 receptor is co-expressed with elements of the kinin-kallikrein, renin-angiotensin and coagulation systems in alveolar cells. | Sci Rep | 2020 | 33177594 | PubTator, text mining | PubMed |
| ACE2: The Major Cell Entry Receptor for SARS-CoV-2. | Lung | 2020 | 33170317 | PubTator, text mining | PubMed |
| Central involvement of SARS-CoV-2 may aggravate ARDS and hypertension. | J Renin Angiotensin Aldosterone Syst | 2020 | 33169637 | PubTator, text mining | PubMed |
| SARS-CoV-2 and interferon blockade. | Mol Med | 2020 | 33167852 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/623/papers?page=32